Genmab A/S Trade Receivables
Genmab A/S (GNMSF) had Trade Receivables of $1.13 billion as of 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes › Receivables
ifrs-full:TradeReceivables · last filed 2026-02-17
- 2024-12-31: Trade Receivables 6.64B DKK.
- 2023-12-31: Trade Receivables 5.01B DKK.
- 2022-12-31: Trade Receivables 5.76B DKK; Trade Receivables as first filed 5.96B DKK.
- 2021-12-31: Trade Receivables 3.39B DKK.
DKK
| Period end | Trade Receivables | Trade Receivables as first filed |
|---|---|---|
| 2024-12-31 | 6.64B DKK 6-K · filed 2025-02-12 | |
| 2023-12-31 | 5.01B DKK 6-K · filed 2025-02-12 | |
| 2022-12-31 | 5.76B DKK 6-K · filed 2024-02-14 | 5.96B DKK 6-K · filed 2023-02-22 |
| 2021-12-31 | 3.39B DKK 6-K · filed 2023-02-22 | |
| 2020-12-31 | 2.48B DKK 6-K · filed 2022-02-16 | |
| 2019-12-31 | 3.00B DKK 6-K · filed 2021-02-23 | |
| 2018-12-31 | 1.34B DKK 20-F · filed 2020-03-30 |
USD
| Period end | Trade Receivables |
|---|---|
| 2025-12-31 | $1.13B 20-F · filed 2026-02-17 |
| 2024-12-31 | $930.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $743.00M 20-F · filed 2026-02-17 |